Kirsten E. Peters

1.3k total citations
48 papers, 971 citations indexed

About

Kirsten E. Peters is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, Kirsten E. Peters has authored 48 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 9 papers in Nephrology. Recurrent topics in Kirsten E. Peters's work include Chronic Kidney Disease and Diabetes (7 papers), Diabetes Treatment and Management (7 papers) and Diabetes Management and Research (5 papers). Kirsten E. Peters is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Diabetes Treatment and Management (7 papers) and Diabetes Management and Research (5 papers). Kirsten E. Peters collaborates with scholars based in Australia, United States and Canada. Kirsten E. Peters's co-authors include Timothy M. E. Davis, Wendy A. Davis, Ann M. Rose, S. A. Paul Chubb, David Bruce, A M Rose, Kim S. McKim, Richard Lipscombe, Martin Srayko and Colin Thacker and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kirsten E. Peters

45 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirsten E. Peters Australia	19	272	205	200	160	148	48	971
Toryn Poolman United Kingdom	16	339 1.2×	93 0.5×	389 1.9×	76 0.5×	58 0.4×	33	1.1k
Mélanie Viltard France	15	346 1.3×	57 0.3×	100 0.5×	96 0.6×	25 0.2×	17	1.2k
Diana Cruz‐Topete United States	18	313 1.2×	399 1.9×	225 1.1×	106 0.7×	19 0.1×	32	1.3k
Kedryn K. Baskin United States	13	756 2.8×	38 0.2×	369 1.8×	127 0.8×	59 0.4×	32	1.3k
Miles J. De Blasio Australia	28	641 2.4×	303 1.5×	416 2.1×	123 0.8×	14 0.1×	79	2.3k
Arsun Bektas United States	12	263 1.0×	30 0.1×	169 0.8×	134 0.8×	47 0.3×	15	942
Yun Shi China	18	204 0.8×	228 1.1×	92 0.5×	90 0.6×	16 0.1×	73	936
Alessio Basolo Italy	18	138 0.5×	322 1.6×	343 1.7×	72 0.5×	14 0.1×	57	880
Chantal Verdumo Switzerland	13	833 3.1×	187 0.9×	243 1.2×	230 1.4×	9 0.1×	17	1.3k
Yunhua L. Muller United States	22	660 2.4×	193 0.9×	296 1.5×	127 0.8×	11 0.1×	54	1.2k

Countries citing papers authored by Kirsten E. Peters

Since Specialization

Citations

This map shows the geographic impact of Kirsten E. Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten E. Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten E. Peters more than expected).

Fields of papers citing papers by Kirsten E. Peters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten E. Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten E. Peters. The network helps show where Kirsten E. Peters may publish in the future.

Co-authorship network of co-authors of Kirsten E. Peters

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten E. Peters. A scholar is included among the top collaborators of Kirsten E. Peters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten E. Peters. Kirsten E. Peters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peters, Kirsten E., Ilse Joubert, Scott Bringans, et al.. (2025). PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes. Diagnostics. 15(6). 662–662. 1 indexed citations

Davis, Timothy M. E., Kirsten E. Peters, & Wendy A. Davis. (2024). Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase II. Internal Medicine Journal. 54(3). 494–498. 3 indexed citations

Davis, Timothy M. E., et al.. (2024). Application of a validated prognostic plasma protein biomarker test for renal decline in type 2 diabetes to type 1 diabetes: the Fremantle Diabetes Study Phase II. SHILAP Revista de lepidopterología. 10(1). 30–30. 1 indexed citations

Bringans, Scott, Kirsten E. Peters, Tammy M. Casey, et al.. (2024). Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis. Human Reproduction. 40(2). 270–279. 5 indexed citations

Davis, Timothy M. E., S. A. Paul Chubb, Kirsten E. Peters, & Wendy A. Davis. (2023). Serum vitamin B12, distal symmetrical polyneuropathy and anaemia in type 2 diabetes: the Fremantle Diabetes Study Phase 2. Internal Medicine Journal. 54(4). 575–581. 1 indexed citations

Chubb, S. A. Paul, Kirsten E. Peters, David Bruce, Wendy A. Davis, & Timothy M. E. Davis. (2022). The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase II. Acta Diabetologica. 59(12). 1615–1624. 8 indexed citations

Drinkwater, Jocelyn J., Kirsten E. Peters, Wendy A. Davis, et al.. (2021). Assessment of biomarkers associated with rapid renal decline in the detection of retinopathy and its progression in type 2 diabetes: The Fremantle Diabetes Study Phase II. Journal of Diabetes and its Complications. 35(4). 107853–107853. 3 indexed citations

Davis, Timothy M. E., Kirsten E. Peters, S. A. Paul Chubb, et al.. (2020). Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. Journal of Clinical Medicine. 9(11). 3409–3409. 1 indexed citations

Bringans, Scott, Tammy M. Casey, Sarah Thomas, et al.. (2020). A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease. Clinical Proteomics. 17(1). 37–37. 6 indexed citations

10.

Peters, Kirsten E., S. A. Paul Chubb, David Bruce, Wendy A. Davis, & Timothy M. E. Davis. (2020). Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II. Clinical Endocrinology. 92(4). 373–382. 17 indexed citations

11.

Peters, Kirsten E., Wendy A. Davis, Jun Ito, et al.. (2019). Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle Diabetes Study Phase II. Journal of Diabetes and its Complications. 33(12). 107406–107406. 20 indexed citations

12.

Davis, Wendy A., Kirsten E. Peters, Ashley Makepeace, et al.. (2018). Prevalence of diabetes in Australia: insights from the Fremantle Diabetes Study Phase II. Internal Medicine Journal. 48(7). 803–809. 49 indexed citations

13.

Yeap, Bu B., Wendy A. Davis, Kirsten E. Peters, et al.. (2017). Circulating osteocalcin is unrelated to glucose homoeostasis in adults with type 1 diabetes. Journal of Diabetes and its Complications. 31(6). 948–951. 7 indexed citations

14.

Bruce, David, Wendy A. Davis, Michael Hunter, et al.. (2015). Lifetime depression history and depression risk in type 2 diabetes: A case-control study. Journal of Diabetes and its Complications. 30(1). 38–42. 18 indexed citations

15.

Bruce, David, Michael Hunter, Kirsten E. Peters, Timothy M. E. Davis, & Wendy A. Davis. (2015). Fear of falling is common in patients with type 2 diabetes and is associated with increased risk of falls. Age and Ageing. 44(4). 687–690. 48 indexed citations

16.

Davis, Wendy A., Kirsten E. Peters, David R. Hillman, et al.. (2014). Effect of continuous positive airway pressure therapy on sexual function and serum testosterone in males with type 2 diabetes and obstructive sleep apnoea. Clinical Endocrinology. 81(2). 254–258. 28 indexed citations

17.

Peters, Kirsten E., John Beilby, Gemma Cadby, et al.. (2013). A comprehensive investigation of variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic syndrome. BMC Medical Genetics. 14(1). 15–15. 68 indexed citations

18.

Peters, Kirsten E., S. A. Paul Chubb, Wendy A. Davis, & Timothy M. E. Davis. (2013). The Relationship between Hypomagnesemia, Metformin Therapy and Cardiovascular Disease Complicating Type 2 Diabetes: The Fremantle Diabetes Study. PLoS ONE. 8(9). e74355–e74355. 45 indexed citations

19.

Davis, Wendy A., et al.. (2012). Effect of Continuous Positive Airway Pressure Therapy on Cardiovascular Risk Factors in Patients with Type 2 Diabetes and Obstructive Sleep Apnea. The Journal of Clinical Endocrinology & Metabolism. 97(11). 4212–4218. 65 indexed citations

20.

Peters, Kirsten E., et al.. (2004). Genetic Disorders in Gastroenterology and Hepatology. Journal of Gastroenterology and Hepatology. 19. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact